CL2019001008A1 - Formas cristalinas de 4–(2–((1r,2r)–2–hidroxiciclohexilamino) benzotiazol–6–iloxi)–n–metilpicolinamida. - Google Patents
Formas cristalinas de 4–(2–((1r,2r)–2–hidroxiciclohexilamino) benzotiazol–6–iloxi)–n–metilpicolinamida.Info
- Publication number
- CL2019001008A1 CL2019001008A1 CL2019001008A CL2019001008A CL2019001008A1 CL 2019001008 A1 CL2019001008 A1 CL 2019001008A1 CL 2019001008 A CL2019001008 A CL 2019001008A CL 2019001008 A CL2019001008 A CL 2019001008A CL 2019001008 A1 CL2019001008 A1 CL 2019001008A1
- Authority
- CL
- Chile
- Prior art keywords
- crystalline forms
- hydroxycyclohexylamino
- methylpicolinamide
- benzothiazol
- yloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ESTA SOLICITUD SE REFIERE A DIVERSAS FORMAS CRISTALINAS DE SALES DE CLORHIDRATO DE 4–(2–((1R,2R)–2–HIDROXICICLOHEXILAMINO)BENZOTIAZOL–6–ILOXI)–N– METILPICOLINAMIDA, AL IGUAL QUE A COMPOSICIONES Y MÉTODOS PARA SU USO. EN ALGUNAS FORMAS DE REALIZACIÓN, LAS FORMAS CRISTALINAS ADEMÁS CONTIENEN AGUA (“HIDRATOS”). ESTOS MATERIALES SON ÚTILES EN EL TRATAMIENTO DE DIVERSAS ENFERMEDADES, QUE INCLUYEN GLIOBLASTOMA MULTIFORME, CÁNCER DE MAMA, CÁNCER DE PÁNCREAS Y OTROS TUMORES SÓLIDOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662408358P | 2016-10-14 | 2016-10-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019001008A1 true CL2019001008A1 (es) | 2019-06-21 |
Family
ID=60320932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019001008A CL2019001008A1 (es) | 2016-10-14 | 2019-04-12 | Formas cristalinas de 4–(2–((1r,2r)–2–hidroxiciclohexilamino) benzotiazol–6–iloxi)–n–metilpicolinamida. |
Country Status (14)
Country | Link |
---|---|
US (1) | US10934273B2 (es) |
EP (1) | EP3526217B1 (es) |
JP (1) | JP7068288B2 (es) |
KR (1) | KR20190064589A (es) |
CN (1) | CN109843880B (es) |
AU (1) | AU2017342239B2 (es) |
BR (1) | BR112019006914A2 (es) |
CA (1) | CA3039764A1 (es) |
CL (1) | CL2019001008A1 (es) |
ES (1) | ES2949414T3 (es) |
IL (1) | IL265893A (es) |
MX (1) | MX2019004345A (es) |
RU (1) | RU2019114208A (es) |
WO (1) | WO2018069892A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008013427A (es) * | 2006-04-19 | 2008-11-04 | Novartis Ag | Compuestos de benzoxazole y benzotiazole sustituidos-6-0 y metodos para inhibir la señalizacion csf-1r. |
CN101432281B (zh) * | 2006-04-19 | 2013-08-28 | 诺瓦提斯公司 | 6-0-取代的苯并*唑和苯并噻唑化合物以及抑制csf-1r信号传导的方法 |
EA023999B1 (ru) * | 2011-05-05 | 2016-08-31 | Новартис Аг | Ингибиторы csf-1r для лечения опухолей головного мозга |
EP3233918A1 (en) * | 2014-12-19 | 2017-10-25 | Novartis AG | Combination therapies |
-
2017
- 2017-10-13 EP EP17797745.1A patent/EP3526217B1/en active Active
- 2017-10-13 KR KR1020197010527A patent/KR20190064589A/ko not_active Application Discontinuation
- 2017-10-13 US US16/341,124 patent/US10934273B2/en active Active
- 2017-10-13 ES ES17797745T patent/ES2949414T3/es active Active
- 2017-10-13 CA CA3039764A patent/CA3039764A1/en not_active Abandoned
- 2017-10-13 AU AU2017342239A patent/AU2017342239B2/en not_active Ceased
- 2017-10-13 RU RU2019114208A patent/RU2019114208A/ru not_active Application Discontinuation
- 2017-10-13 BR BR112019006914A patent/BR112019006914A2/pt not_active IP Right Cessation
- 2017-10-13 WO PCT/IB2017/056379 patent/WO2018069892A1/en unknown
- 2017-10-13 JP JP2019520040A patent/JP7068288B2/ja active Active
- 2017-10-13 MX MX2019004345A patent/MX2019004345A/es unknown
- 2017-10-13 CN CN201780063254.XA patent/CN109843880B/zh active Active
-
2019
- 2019-04-07 IL IL265893A patent/IL265893A/en unknown
- 2019-04-12 CL CL2019001008A patent/CL2019001008A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ES2949414T3 (es) | 2023-09-28 |
JP2019530719A (ja) | 2019-10-24 |
CA3039764A1 (en) | 2018-04-19 |
US20200190057A1 (en) | 2020-06-18 |
MX2019004345A (es) | 2019-07-01 |
WO2018069892A1 (en) | 2018-04-19 |
CN109843880B (zh) | 2023-12-01 |
EP3526217B1 (en) | 2023-04-19 |
EP3526217A1 (en) | 2019-08-21 |
AU2017342239B2 (en) | 2020-05-28 |
JP7068288B2 (ja) | 2022-05-16 |
IL265893A (en) | 2019-06-30 |
AU2017342239A1 (en) | 2019-04-18 |
CN109843880A (zh) | 2019-06-04 |
RU2019114208A (ru) | 2020-11-16 |
BR112019006914A2 (pt) | 2019-07-02 |
RU2019114208A3 (es) | 2020-11-18 |
US10934273B2 (en) | 2021-03-02 |
KR20190064589A (ko) | 2019-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000376A1 (es) | Derivados heterobicíclicos microbicidas. | |
CY1125205T1 (el) | Φαρμακευτικες συνθεσεις δραστικων απο θεραπευτικη αποψη ενωσεων | |
CO2017004782A2 (es) | Conjugados de anticuerpo- farmaco | |
CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
EA201790766A1 (ru) | Новые соединения метилпиперидина, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
BR112016026291A2 (pt) | Derivados do ácido borônico e usos terapêuticos dos mesmos | |
CU20160149A7 (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados y su uso como inhibidores de irak4 | |
BR112015030011A2 (pt) | composições e métodos para intensificar a germinação | |
BR112015023753A2 (pt) | composições, formulações e métodos para o tratamento de doenças oculares | |
CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
DOP2017000107A (es) | Diamino-quinoleina 2,4 sustituida como nuevos agentes anticancerigenos | |
CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
UY35293A (es) | Isotiazoles sustituidos con amino | |
EA201790627A1 (ru) | СТИМУЛЯТОРЫ рГЦ | |
PE20181287A1 (es) | Ciano tienotriazolpirazinas y usos de las mismas | |
CL2019003670A1 (es) | Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta. | |
MA49152A (fr) | Schémas posologiques d'immunoconjugués anti-cd33 | |
AR101486A1 (es) | Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso | |
UY36261A (es) | Anticuerpos anti proteína similar a angiopoyetina-4 (angptl4) y métodos de uso | |
BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso | |
CL2019001008A1 (es) | Formas cristalinas de 4–(2–((1r,2r)–2–hidroxiciclohexilamino) benzotiazol–6–iloxi)–n–metilpicolinamida. | |
BR112018074231A2 (pt) | compostos bicíclicos fundidos para o tratamento de doença | |
CL2018002848A1 (es) | Formulaciones liquidas de fosfoplatino | |
CL2016003230A1 (es) | Compuestos, composición farmacéutica y su uso en el tratamiento de enfermedades neurodegenerativas | |
ITUA20162517A1 (it) | Composizione per la conservazione/fissazione di materiale biologico |